1. Boston PF, Dursun SM, Reveley MA. Cholesterol and mental disorder. Br J Psychiatry. 1996. 169:682–689.
Article
2. Steinert T, Woelfle M, Gebhardt RP. No correlation of serum cholesterol levels with measures of violence in patients with schizophrenia and non-psychotic disorders. Eur Psychiatry. 1999. 14:346–348.
Article
3. Vikkunen MD. Serum cholesterol in anti-social personality. Neuropsychobiology. 1994. 5:27–30.
Article
4. Alverez JC, Cremniter D, Gluck N, Quintin P, Leboyer M, Berlin I, Therond P, Spreux-Varoquaux O. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res. 2000. 95:103–108.
5. Bond AJ. Serum cholesterol, triglycerides, and aggression in the general population. Br J Psychiatry. 1993. 163:666–668.
6. Tripodianakis J, Markianos M, Sarantidis D, Agouridaki M. Biogenic amine turnover and serum cholesterol in suicide attempt. Eur Arch Psychiatry Clin Neurosci. 2002. 252:38–43.
Article
7. Buydens-Branchey L, Branchey M, Hudson J, Fergeson P. Low HDL cholesterol, aggression and altered central serotonergic activity. Psychiatry Res. 2000. 93:93–102.
Article
8. Repo-Tiihonen E, Halonen P, Tiihonen J, Virkkunen M. Total serum cholesterol level, violent criminal offences, suicidal behavior, mortality and the appearance of conduct disorder in Finnish male criminal offenders with antisocial personality disorder. Eur Arch Psychiatry Clin Neurosci. 2002. 252:8–11.
Article
9. Yates WR, Wallace R. Cardiovascular risk factors in affective disorder. J Affect Disord. 1987. 12:129–134.
Article
10. Oxenkrug GF, Branconnier RJ, Harto-Truax N, Cole JO. Is serum cholesterol a biological marker for major depressive disoder? Am J Psychiatry. 1983. 140:920–921.
11. Dealberto MJ, Ducimetiere P, Mainard F, Alperovitch A. Serum lipids and depression. Lancet. 1993. 341:435.
12. Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL. Plasma cholesterol and depressive symptoms in older men. Lancet. 1993. 341:75–79.
Article
13. Cassidy F, Carroll BJ. Hypocholesterolemia during mixed manic episodes. Eur Arch Psychiatry Clin Neurosci. 2002. 252:110–114.
Article
14. Bajwa WK, Asnis GM, Sanderson WC, Irfan A, van Praag HM. High cholesterol levels in patients with panic disorder. Am J Psychiatry. 1992. 149:376–378.
15. Shioiri T, Fujii K, Someya T, Takahashi S. Serum cholesterol levels and panic symptoms in patients with panic disorder: a preliminary study. J Affect Disorders. 2000. 58:167–170.
Article
16. Kuczmierczyk AR, Barbee JG, Bologna NA, Townsend MH. Serum cholesterol levels in patients with generalized anxiety disorder (GAD) and with GAD and comorbid major depression. Can J Psychiatry. 1996. 41:465–468.
Article
17. Sevincok L, Buyukozturk A, Dereboy F. Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder. Can J Psychiatry. 2001. 46:68–71.
Article
18. Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F, Wittich M. Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. Can J Psychiatry. 2002. 47:557–561.
Article
19. Kagan BL, Leskin G, Haas B, Wilkins J, Foy D. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999. 45:374–377.
Article
20. Solter V, Thaller V, Karlović D, Crnković D. Elevated serum lipids in veterans with combat-related chronic posttraumatic stress disorder. Croat Med J. 2002. 43:685–689.
21. Zoričić Z, Karlović D, Buljan D, Marušić S. Comorbid alcohol addiction increases aggression level in soldiers with combat-related posttraumatic stress disorder. Nord J Psychiatry. 2003. 57:199–202.
22. Kozarić-Kovačić D, Hercigonja DK, Grubišić-Ilić M. Posttraumatic stress disorder and depression in soldiers with combat experiences. Croat Med J. 2001. 42:165–170.
23. Stahl S. Essential psychopharmacology. Neuroscientific basis and practical applications. 2002. Cambridge: Cambridge University Press;199–295.
24. Thaller V, Breitenfeld D, Buljan D. Alcohol consumption among Croatian combat veterans. Eur J Psychiat. 1997. 11:43–50.
25. American Psychiatric Association. Diagnostic and statistic manual of mental disorders. 1994. IV. Washington DC: American Psychiatric Association.
26. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995. 8:75–90.
Article
27. Montgomery SA, Asperg M. A new depression scale designed to be sensitive to change. Brit J Psychiatry. 1979. 134:382–389.
Article
28. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989. 298:784–788.
Article
29. Eastham RD. Biochemical values in clinical medicine. 1978. London: John wright & Sons;103–109.
30. Zoričić Z, Buljan D, Thaller V, Karlović D. Aggression in posttraumatic stress disorder comorbid with alcohol dependence. Eur J Psychiat. 2003. 17:243–247.
31. Karlović D, Kozarić-Kovačić D, Kocijan-Hercigonja D. Elevation of serum total triiodothironine and free triiodothironine in Croatian veterans with combat-related post-traumatic stress disorder. Mil Med. 2002. 167:846–849.
Article
32. Thaller V, Marušić S, Katinić K, Buljan D, Golik-Gruber V, Potkonjak J. Biological factors in patients with post-traumatic stress disorder and alcoholism. Eur J Psychiat. 2003. 17:87–98.
33. McCann BS, Magee MS, Broyles FC, Vaughan M, Albers JJ, Knopp RH. Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: effects on plasma lipid and apoprotein concentrations. Psychosom Med. 1995. 57:165–176.
34. Kjeldsen SE, Rostrup M, Moan A, Mundal HH, Gjesdal K, Eide IK. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension. J Cardiovasc Pharmacol. 1992. 20:S32–S39.
Article
35. Southwick SM, Bremner JD, Rasmusson A, Morgan CA 3rd, Arnsten A, Charney DS. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry. 1999. 46:1192–1204.
Article
36. Kjeldsen SE, Rostrup M, Moan A, Murdal HH, Gjesdal K, Eide IK. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension. J Cardiovasc Pharmacol. 1992. 20:Suppl 8. S32–S39.
Article
37. McCann BS, Magee S, Broyles FC, Vaughan M, Albers JJ, Knopp RH. Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: effects on plasma lipid and apoprotein concentrations. Psychosom Med. 1995. 57:165–176.
38. Quiziblash N, Duffy SW, Warlow C, Mann JI. Lipids are risk factors for ischemic stroke: overview and review. Cerebrovasc Dis. 1992. 2:127–136.